Glatt: Multiparticulates as modern oral drug products
Multiparticulates such as micropellets, pellets, granules and mini-tablets represent modern and innovative technology platforms. Multiparticulates can provide a number of advantages compared with larger-sized monolithic forms such as tablets. Increasing compliance is achieved for children – from birth to adolescence – and elderly. Individually tailored drug release profiles for any API and site specific drug delivery allow for an optimized and safe therapeutic effect.
Learn more about the innovative solutions in this webinar held by Dr. Norbert Pöllinger, Head of Technology Development at Glatt. Pharmaceutical Services